CGC 2022 Keynote Presentation - Advances in Diagnosis and Treatment of Neurofibromatosis 1

CGC 2022 Keynote Presentation - Advances in Diagnosis and Treatment of Neurofibromatosis 1

Prof.Roger Packer- New Horizons in the Management of Neurofibromatosis Type1 Plexiform NeurofibromasПодробнее

Prof.Roger Packer- New Horizons in the Management of Neurofibromatosis Type1 Plexiform Neurofibromas

Neurofibromatosis, Causes, Signs and Symptoms, Diagnosis and Treatment.Подробнее

Neurofibromatosis, Causes, Signs and Symptoms, Diagnosis and Treatment.

NF Summit 2022: Cutaneous Neurofibromas, Understanding the Natural History for Better TreatmentsПодробнее

NF Summit 2022: Cutaneous Neurofibromas, Understanding the Natural History for Better Treatments

Clinical Guidlines: Tumour Management in NF1Подробнее

Clinical Guidlines: Tumour Management in NF1

Kenneth Rudd Shares His Story About Living with Neurofibromatosis Type 1Подробнее

Kenneth Rudd Shares His Story About Living with Neurofibromatosis Type 1

ERN-EYE webinar (3rd February 2022): Neurofibromatosis 1 & 2: An OverviewПодробнее

ERN-EYE webinar (3rd February 2022): Neurofibromatosis 1 & 2: An Overview

Nerve Tumors NeurofibromatosisПодробнее

Nerve Tumors Neurofibromatosis

CGC 2022 Keynote Presentation - Using Genomics to Build Better Cancer VaccinesПодробнее

CGC 2022 Keynote Presentation - Using Genomics to Build Better Cancer Vaccines

NF Summit 2022: Genetics 101 and VCEP/Genetic Modifiers and Cutaneous NeurofibromasПодробнее

NF Summit 2022: Genetics 101 and VCEP/Genetic Modifiers and Cutaneous Neurofibromas

Clinical Trials for the Treatment of NF: Past, Present and Future; Brigitte Widemann, MDПодробнее

Clinical Trials for the Treatment of NF: Past, Present and Future; Brigitte Widemann, MD

Managing Symptoms of NF1Подробнее

Managing Symptoms of NF1

NF1 With PNs: Future of Treatment With MEK InhibitorsПодробнее

NF1 With PNs: Future of Treatment With MEK Inhibitors

Clinical Trials for the Treatment of NF: Past, Present and Future; Elizabeth Schorry, MDПодробнее

Clinical Trials for the Treatment of NF: Past, Present and Future; Elizabeth Schorry, MD

SpringWorks Therapeutics and the ReNeu Trial for NF1-Related Plexiform NeurofibromasПодробнее

SpringWorks Therapeutics and the ReNeu Trial for NF1-Related Plexiform Neurofibromas

Cutaneous Neurofibromas: options to prevent them from growing in the foreseeable futureПодробнее

Cutaneous Neurofibromas: options to prevent them from growing in the foreseeable future

CF Foundation | NACFC 2022 HighlightsПодробнее

CF Foundation | NACFC 2022 Highlights

Paraspinal neurofibromas in spinal neurofibromatosis type 1 (NF1)Подробнее

Paraspinal neurofibromas in spinal neurofibromatosis type 1 (NF1)

NACFC 2022 | W28: Clinical Genetics and BeyondПодробнее

NACFC 2022 | W28: Clinical Genetics and Beyond